- Home
- VIR vs KOS Comparison
VIR vs KOS Comparison
Compare VIR & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- KOS
- Stock Information
- Founded
- VIR 2016
- KOS 2003
- Country
- VIR United States
- KOS United States
- Employees
- VIR N/A
- KOS N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- KOS Oil & Gas Production
- Sector
- VIR Health Care
- KOS Energy
- Exchange
- VIR Nasdaq
- KOS Nasdaq
- Market Cap
- VIR 706.4M
- KOS 822.2M
- IPO Year
- VIR 2019
- KOS 2011
- Fundamental
- Price
- VIR $4.56
- KOS $1.76
- Analyst Decision
- VIR Strong Buy
- KOS Buy
- Analyst Count
- VIR 8
- KOS 6
- Target Price
- VIR $30.25
- KOS $4.52
- AVG Volume (30 Days)
- VIR 1.0M
- KOS 9.3M
- Earning Date
- VIR 08-06-2025
- KOS 08-04-2025
- Dividend Yield
- VIR N/A
- KOS N/A
- EPS Growth
- VIR N/A
- KOS N/A
- EPS
- VIR N/A
- KOS N/A
- Revenue
- VIR $19,000,000.00
- KOS $1,488,836,000.00
- Revenue This Year
- VIR N/A
- KOS N/A
- Revenue Next Year
- VIR $0.56
- KOS $11.18
- P/E Ratio
- VIR N/A
- KOS N/A
- Revenue Growth
- VIR N/A
- KOS N/A
- 52 Week Low
- VIR $4.16
- KOS $1.39
- 52 Week High
- VIR $14.45
- KOS $5.08
- Technical
- Relative Strength Index (RSI)
- VIR 37.28
- KOS 36.35
- Support Level
- VIR $4.33
- KOS $1.69
- Resistance Level
- VIR $4.63
- KOS $1.81
- Average True Range (ATR)
- VIR 0.23
- KOS 0.13
- MACD
- VIR -0.05
- KOS -0.04
- Stochastic Oscillator
- VIR 26.82
- KOS 2.00
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.